3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition

Abstract

Abstract. 3-Methyladenine (3-MA) inhibits class III phosphoinositide 3-kinase (PI3K) and is widely used as an inhibitor of autophagy. 3-MA has also been shown to stimulate cell death of tumor cells under nutrient-starved conditions by inhibiting autophagy. To explore the possibility of this type of autophagy inhibitors as anticancer drugs, we examined the effects of 3-MA on the phenotypes of highly metastatic human fibrosarcoma HT1080 cells. We report here that although 3-MA did not markedly affect cell survival of the cells under either normal or amino acid-starved conditions, it strongly inhibited the invasiveness of the cells. 3-MA rapidly suppressed actin rich membrane ruffle and/or lamellipodia formation under normal conditions, leading to inhibition of cell migration and invasion of the cells without substantial inhibitions of small GTPase Rac activity and the production of matrix metalloproteinases MMP-2 and MMP-9. 3-MA abolished class I and class II PI3Ks in in vitro lipid kinase assays, and suppressed cell motility of the cells more strongly than the other PI3K inhibitors wortmannin and LY294002. Downregulation of Beclin 1, a protein required for autophagic body formation, by transfection of Beclin 1 siRNA did not inhibit membrane ruffle formation and cell migration. These results suggest that 3-MA suppresses the invasion of HT1080 cells, independently of autophagy inhibition, through inhibition of type I and II PI3Ks and possibly other molecules.

Long Non-coding RNA GAS5 Functions as a Tumor Suppressor in Renal Cell Carcinoma

“…Potentiality of cell invasion and migration were measured by an in vitro Transwell (Millipore, Billerica, MA) assay as previously described (Ito et al, 2007). After 24 h transfection, cells were serum starved overnight.…”

Clarithromycin attenuates autophagy in myeloma cells

“…CAM may disrupt this rescue pathway thus resulting in cell death in vivo as we found vacuole formations in primary MM cells. This concept has been reported by Ito et al, showing inhibition of autophagy results various anti-tumor effects in malignant tumors (23,24).…”

Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies

“…It is noteworthy that both yeast and human Vps34 share a lysine residue that, in human class I PI3Ks, is the site of covalent modification by the pan-PI3K inhibitor wortmannin (Wymann et al, 1996;Walker et al, 2000). Indeed, Vps34 is inhibited by both wortmannin and LY294002 (Backer, 2008), and although 3-methyladenine (3MA) has been suggested to be a specific inhibitor of hVps34, in fact it inhibits class I and II PI3Ks as well (Ito et al, 2007). However, the crystal structure of Vps34 in complex with 3MA has been solved .…”